AstraZeneca Pharma India Ltd.

NSE: ASTRAZEN | BSE: 506820

Expensive Underperformer

Download real time

8036.00 -50.00 (-0.62%)

3,661

NSE+BSE Volume

NSE 17 Jul, 2026 10:03 AM (IST)

CDSCO Approval

AstraZeneca Pharma gets CDSCO nod for Benralizumab sol, with a market size of up to $2 bn in 2025 See details

AstraZeneca Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents